Related Experiment Video
Updated: May 5, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
[Measure of disease impact: instrument construct validity in patients with coronary artery disease]
Rafaela Batista dos Santos Pedrosa1, Roberta Cunha Matheus Rodrigues, Kátia Melissa Padilha
1Departamento de Enfermagem, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, CampinasSP, Brasil, rafaphn@fcm.unicamp.br.
Insights
The Instrument to Measure the Impact of Coronary Disease on Patient
Area of Science:
- Cardiology
- Health Psychology
- Psychometrics
Context:
- Coronary artery disease (CAD) significantly impacts patients' daily lives.
- Accurate measurement of disease impact is crucial for effective patient management.
- Existing instruments may require further validation in diverse populations.
Purpose:
- To assess the known groups construct validity of the Instrument to Measure the Impact of Coronary Disease on Patient's Everyday Life (IDCV).
- To evaluate the IDCV's ability to discriminate between different levels of disease severity and health-related quality of life (HRQoL).
Summary:
- The study validated the IDCV in 153 coronary artery disease outpatients using the SF-36 and MacNew questionnaires.
- Statistical tests (Mann-Whitney, Kruskal-Wallis) confirmed the IDCV's ability to differentiate impact based on signs/symptoms, left ventricular ejection fraction (LVEF), and HRQoL.
- The IDCV successfully discriminated impact across different HRQoL quartiles.
Impact:
- Findings support the IDCV's utility in measuring the impact of coronary artery disease on patients' everyday lives.
- This validation contributes to refining psychometric tools for assessing patient-reported outcomes in cardiology.
- Improved measurement tools can lead to better-tailored interventions and enhanced patient care in coronary artery disease management.
Abstract:
This study estimated the known groups construct validity for the Instrument to Measure the Impact of Coronary Disease on Patient's Everyday Life (IDCV) related to signs and symptoms, ventricular systolic function, left ventricular ejection fraction (LVEF) and health-related quality of life (HRQoL) in 153 outpatients with coronary artery disease. Data was obtained through application of IDCV and Brazilian versions of the instruments The Medical Study 36-item Short Form Health Survey - SF-36 and the MacNew Heart Disease Health-related Quality of Life Questionnaire . Mann-Whitney test was used to verify the ability of IDCV in discriminating impact of signs and symptoms, LVEF and ventricular systolic dysfunction. Also, the Kruskal-Wallis test was used to verify the discrimination power of the IDCV in relation to HRQoL. It was observed that the IDCV discriminated the impact between variables scored in HRQOL quartiles (≤Q1, Q1-Q3, ≥Q3). The study findings contribute for improvement of IDCV in measurement of disease impact in coronary artery disease patients.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction